(FY)Feb 29, 2024 | |
---|---|
Operating Cash Flow (Indirect Method) | |
Cash flow from continuing operating activities | -307.87K |
Net income from continuing operations | ---320.55K |
Change In working capital | --12.68K |
-Change in receivables | ---4.56K |
-Change in prepaid assets | ---5K |
-Change in payables and accrued expense | --85.22K |
-Change in other working capital | ---62.97K |
Cash from discontinued investing activities | |
Operating cash flow | ---307.87K |
Investing cash flow | |
Cash flow from continuing investing activities | -18K |
Net PPE purchase and sale | ---18K |
Cash from discontinued investing activities | |
Investing cash flow | ---18K |
Financing cash flow | |
Cash flow from continuing financing activities | 786.52K |
Net common stock issuance | --797.08K |
Net other financing activities | ---10.56K |
Cash from discontinued financing activities | |
Financing cash flow | --786.52K |
Net cash flow | |
Beginning cash position | --0 |
Current changes in cash | --460.66K |
End cash Position | --460.66K |
Free cash from | ---325.87K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.